Education
About Us
Working with TipRanks
Follow Us
Kane Biotech (TSE:KNE)
:KNE
KNE Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.09 - C$0.17
Previous CloseN/A
Volume199.87K
Average Volume (3M)27.59K
Market Cap
C$13.06M
Enterprise ValueC$20.47M
Total Cash (Recent Filing)C$568.25K
Total Debt (Recent Filing)C$0.00
Price to Earnings (P/E)―
Beta0.47
Next Earnings
May 22, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding137,511,570
10 Day Avg. Volume20,550
30 Day Avg. Volume27,589
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)308.73
Price to Cash Flow (P/CF)-7.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Kane Biotech News
PremiumCompany Announcements
Kane Biotech Revises Marketing Agreement with Outside the Box Capital
PremiumCompany Announcements
Kane Biotech Secures Approval for DispersinB® Acne Trial
PremiumCompany Announcements
Kane Biotech Finalizes $1.7 Million Private Placement Offering
PremiumCompany Announcements
Kane Biotech Unveils 2025 Strategy and Marketing Push
PremiumCompany Announcements
Kane Biotech’s Promising Q3 and Strategic AdvancesPremiumCompany Announcements
Kane Biotech Partners with BioStem for U.S. Distribution---
Options Prices
Currently, No data available
---
Ownership Overview
39.21% Insiders
―
Mutual Funds
― Other Institutional Investors
60.79% Public Companies and
Individual Investors
KNE FAQ
What was Kane Biotech’s price range in the past 12 months?
Kane Biotech lowest stock price was C$0.09 and its highest was C$0.17 in the past 12 months.
What is Kane Biotech’s market cap?
Kane Biotech’s market cap is C$13.06M.
When is Kane Biotech’s upcoming earnings report date?
Kane Biotech’s upcoming earnings report date is May 22, 2025 which is in 28 days.
How were Kane Biotech’s earnings last quarter?
Currently, no data Available
Is Kane Biotech overvalued?
According to Wall Street analysts Kane Biotech’s price is currently Overvalued.
Does Kane Biotech pay dividends?
Kane Biotech does not currently pay dividends.
What is Kane Biotech’s EPS estimate?
Kane Biotech’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Kane Biotech have?
Kane Biotech has 137,511,570 shares outstanding.
What happened to Kane Biotech’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Kane Biotech?
Currently, no hedge funds are holding shares in TSE:KNE
---
Company Description
Kane Biotech
Kane Biotech Inc. is a biotechnology company specializing in the research and development of technologies and products that prevent and remove microbial biofilms. Operating within the life sciences sector, the company focuses on health care and consumer product markets. Its core products include biofilm-targeting solutions used in medical, animal health, and personal care applications. Kane Biotech's innovations aim to enhance the efficacy of antimicrobials and increase the longevity and effectiveness of products across various industries.
---
Technical Analysis
---